Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ReShape Lifesciences Inc. (OBLN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenue  13.611.33.39.19.93.44.03.5
            Revenue growth  20.4%244.4%-63.9%-8.2%192.2%-16.0%14.1% 
Cost of revenue  5.35.03.0     
    Gross profit  8.36.30.33.75.10.61.50.6
            Gross margin  61.4%55.4%10.1%40.4%51.3%17.2%38.0%17.7%
   
Operating expenses:          
Sales and marketing  33.615.216.729.928.810.23.54.7
General and administrative  24.410.5      
Research and development  2.53.56.910.710.69.913.05.8
    Total operating expenses  64.818.723.640.639.520.116.510.5
    Operating loss  -56.5-12.5-23.2-37.0-34.4-19.5-14.9-9.8
            Operating margin  -415.4%-110.2%-708.0%-406.2%-346.9%-574.9%-369.7%-278.0%
   
Other expense (income), net:          
Interest income, net  -0.8-2.0-0.4-0.2-0.1-0.5-0.5-0.2
Gain on changes in fair value of liability warrants       -0.50.00.2
(Gain) loss on foreign currency exchange, net  -0.2-0.4      
Other    -0.1-0.2-0.20.00.00.0
    Loss before income tax provision  -62.0-21.8      
Income tax expense  -0.1-0.2      
    Net loss  -61.9-21.6-23.7-37.4-34.8-20.5-15.6-9.9
   
Net loss per share - basic and diluted:          
Net loss per share - basic (in dollars per share)  ($5.00)($5.54)($5.03)($19.64)($2.08)($4.85)($27.14)($18.61)
Net loss per share - diluted (in dollars per share)  ($5.00)($5.54)($5.03)($19.64)($2.08)($4.85)($27.14)($18.61)
   
Shares used to compute basic net loss per share (in shares)  12.43.94.71.916.74.20.60.5
Shares used to compute diluted net loss per share (in shares)  12.43.9      

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy